GLABELLAR LINES
Clinical trials for GLABELLAR LINES explained in plain language.
Never miss a new study
Get alerted when new GLABELLAR LINES trials appear
Sign up with your email to follow new studies for GLABELLAR LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wrinkle treatment shows promise in asian trial
Symptom relief CompletedThis completed Phase 3 study tested an investigational botulinum toxin injection called AGN-151586 against a placebo for treating moderate to severe frown lines (glabellar lines). About 160 adults in China, Taiwan, and Japan received either the active injection or a placebo into …
Matched conditions: GLABELLAR LINES
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New frown line combo treatment under study
Symptom relief CompletedThis study tested whether giving an experimental drug called AGN-151586 before BOTOX is safe and effective for treating moderate to severe frown lines between the eyebrows. About 90 adults received either the experimental drug or a placebo first, then BOTOX a month later. Researc…
Matched conditions: GLABELLAR LINES
Phase: PHASE1 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New wrinkle treatment aims to rival botox in Head-to-Head trial
Symptom relief CompletedThis phase 3 trial tests whether a new botulinum toxin type A injection, called INI101, works as well as Botox for treating moderate to severe frown lines between the eyebrows. About 292 adults aged 19 to 65 with at least moderate lines at maximum frown will receive a single dose…
Matched conditions: GLABELLAR LINES
Phase: PHASE3 • Sponsor: INIBIO Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New combo treatment targets Crow's feet and hollow eyes
Symptom relief CompletedThis completed study observed 29 adults receiving a combination of botulinum toxin (Letybo), hyaluronic acid filler (Saypha Volume Plus), and polynucleotide injections (Philart Eye) around the eyes. The goal was to see how well this holistic approach reduces wrinkles and restores…
Matched conditions: GLABELLAR LINES
Sponsor: Yuvell • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New Frown-Line treatment shows promise in large trial
Symptom relief CompletedThis study tested a new botulinum toxin, AGN-151586, for treating moderate to severe frown lines between the eyebrows. About 300 adults who had never received any botulinum toxin treatment were randomly assigned to get either the study drug or a placebo. The main goal was to see …
Matched conditions: GLABELLAR LINES
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Botox study shows promise for smoothing upper face wrinkles
Symptom relief CompletedThis study looked at how safe and effective a type of Botox (Letibotulinumtoxin A) is for treating wrinkles in the upper face, like frown lines, forehead lines, and crow's feet. Twenty adults under 75 with moderate to severe wrinkles received injections and were followed for 4 mo…
Matched conditions: GLABELLAR LINES
Sponsor: Yuvell • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New wrinkle treatment combo shows promise in early trial
Symptom relief CompletedThis early-stage study tested whether a new drug called AGN-151586 can be safely combined with BOTOX to treat moderate to severe frown lines between the eyebrows. Researchers monitored 132 healthy adults for side effects and immune responses after a single treatment session. The …
Matched conditions: GLABELLAR LINES
Phase: PHASE1 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New frown line injection shows promise in early trial
Symptom relief CompletedThis study tested a new botulinum toxin injection (OnabotulinumtoxinA X) for treating moderate to severe frown lines between the eyebrows. 328 adults received either the active injection or a placebo. Researchers measured wrinkle improvement and tracked any side effects. The goal…
Matched conditions: GLABELLAR LINES
Phase: PHASE2 • Sponsor: Allergan • Aim: Symptom relief
Last updated Jun 26, 2026 15:01 UTC